HCC
SLXP

Hirtle Callaghan & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Hirtle Callaghan & Co’s Portfolio SLXP Stock Details SLXP Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,000
Closed -$230K – 481
2014
Q4 		$230K Buy
+2,000
New +$230K 0.05% 181